| |
|
|
|
The Center for Professional Advancement, New Brunswick, NJ
May 19-22, 2008
Who Should Attend
This is an introductory-level course for the non-specialist interested in learning the basics of biotechnology. It presents essential information for personnel involved in, or contemplating participation in, biochemically-related and biotechnological research, supervision, scale-up or manufacture. It is most useful for:- Non-specialist Scientific Personnel
- Engineers
- Chemists
- Technical Operations Personnel
- Lawyers
This course is not intended for those with extensive background in the field. Description
With the rapid developments in genetic engineering, it has become increasingly important to have a firm background in the basics pertaining to this area of research and technology. This course is designed to provide these fundamentals. The course will present the properties and manipulation of genetic material and will examine the primary gene product–the protein. Details of current approaches for making recombinant DNA and its use will be emphasized. Participants will be introduced to the fundamentals of genetic engineering through a study of molecular biology pertaining to the biochemistry of DNA and RNA, their structure and synthesis. Transfer of genetic information and its expression into product will provide the necessary background for the study of genetic engineering techniques. The course will focus on the basics of cutting and splicing DNA (gene cloning) and of introducing recombinant DNA into cells for expression into product. The state-of-the-art techniques for manufacturing and purifying a product will also be presented.
|
|
|
|
|
|
|
|
Organized by:
|
|
The Center for Professional Advancement |
|
|
Invited Speakers:
|
|
Ronald A. Pepin, Ph.D.; Senior Vice President, Business Development, Medarex, Inc.
Dr. Ronald A. Pepin is Sr. V. P., Business Development at Medarex, Inc. a biopharmaceutical company focused on treating human diseases by generating fully human monoclonal antibody drugs in their proprietary HuMab mouse.
He received his B.A. degree in biology at Tufts University and his Ph.D. in genetics from Georgetown University. His thesis research involved a novel bacterial cell fusion system to study gene expression.
Dr. Pepin was a postdoctoral research associate at the Banting and Best Department of Medical Research at the University of Toronto during which time he constructed plasmids to study protein biosynthesis. He was a postdoctoral fellow in the Department of Biochemistry at Case Western Reserve University where he succeeded in cloning the four catalytic components of the human pyruvate dehydrogenase complex. He has served as the Manager of Molecular Genetics at Interferon Sciences, Inc., and has set up and directed the research in other biotechnology companies.
Dr. Pepin was previously the Executive Director of External Science and Technology at Bristol-Myers Squibb Company where he was involved in forging Bristol-Myers Squibb's alliances with biotechnology companies.
|
|
|
|
|
|
|
|
Deadline for Abstracts:
|
|
n/a
|
|
|
|
|
|
|
|
Registration:
|
|
Please click here for registration information.
|
|
|
E-mail:
|
|
info@cfpa.com
|
|
|
|
|
|
|
|
|